Company intelligence / Profile preview

PRB Pharmaceuticals

Fountain Valley, California, United States

Ownership: Private
Development stage: Other

Overview

PRB Pharmaceuticals is a biopharmaceutical company that specialized in the development of broad-spectrum antiviral drugs for the treatment of respiratory viral infections. The company's primary focus was on its lead candidate, Vira 38 (PRB-101), which was investigated for its efficacy against influenza and the SARS coronavirus. PRB's research aimed to address unmet needs in infectious disease management, particularly during global health crises such as the avian flu and SARS outbreaks. Despite early clinical progress and collaborations with academic institutions, the company is currently considered inactive.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

University of Hong Kong

Beyond the preview

Go deeper on PRB Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRB Pharmaceuticals.

Explore the full profile